Acorah Software Products - Accounts Production 19.1.200 false true 31 July 2024 1 August 2023 false true No description of principal activity 1 August 2024 31 July 2025 31 July 2025 11476723 Mr Vishaal Sood iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 11476723 2024-07-31 11476723 2025-07-31 11476723 2024-08-01 2025-07-31 11476723 frs-core:CurrentFinancialInstruments 2025-07-31 11476723 frs-bus:PrivateLimitedCompanyLtd 2024-08-01 2025-07-31 11476723 frs-bus:FilletedAccounts 2024-08-01 2025-07-31 11476723 frs-bus:Micro-entities 2024-08-01 2025-07-31 11476723 frs-bus:AuditExempt-NoAccountantsReport 2024-08-01 2025-07-31 11476723 frs-bus:Director1 2024-08-01 2025-07-31 11476723 2023-07-31 11476723 2024-07-31 11476723 2023-08-01 2024-07-31 11476723 frs-core:CurrentFinancialInstruments 2024-07-31
Registered number: 11476723
VKS Pharma Ltd
Unaudited Financial Statements
For The Year Ended 31 July 2025
Balance Sheet
Registered number: 11476723
2025 2024
£ £
Current assets 707 21,260
Creditors: Amounts Falling Due Within One Year (4,443 ) (18,362 )
NET CURRENT ASSETS (LIABILITIES) (3,736 ) 2,898
TOTAL ASSETS LESS CURRENT LIABILITIES (3,736 ) 2,898
Accruals and deferred income - (600 )
NET (LIABILITIES)/ASSETS (3,736 ) 2,298
CAPITAL AND RESERVES (3,736 ) 2,298

Notes

1. General Information
VKS Pharma Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 11476723 . The registered office is 1 Cardiff Way, Liverpool, England, L19 2HA.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 2 (2024: 2)
2 2
For the year ending 31 July 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Mr Vishaal Sood
Director
28/04/2026